Haruki Kaku

974 total citations
35 papers, 757 citations indexed

About

Haruki Kaku is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Haruki Kaku has authored 35 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Genetics and 8 papers in Oncology. Recurrent topics in Haruki Kaku's work include Virus-based gene therapy research (9 papers), Cancer Research and Treatments (6 papers) and Epigenetics and DNA Methylation (6 papers). Haruki Kaku is often cited by papers focused on Virus-based gene therapy research (9 papers), Cancer Research and Treatments (6 papers) and Epigenetics and DNA Methylation (6 papers). Haruki Kaku collaborates with scholars based in Japan, China and United States. Haruki Kaku's co-authors include Hiromi Kumon, Yasutomo Nasu, Masami Watanabe, Takashi Saika, Shin Ebara, Peng Huang, Tomoyasu Tsushima, Masakiyo Sakaguchi, Nam-ho Huh and Fernando Abarzúa and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and The Journal of Urology.

In The Last Decade

Haruki Kaku

34 papers receiving 732 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haruki Kaku Japan 16 447 189 188 129 78 35 757
Waleed Arafat Egypt 21 632 1.4× 375 2.0× 388 2.1× 134 1.0× 190 2.4× 57 1.2k
Ida Casciano Italy 20 658 1.5× 133 0.7× 262 1.4× 42 0.3× 272 3.5× 47 1.1k
Nora Krull Germany 12 368 0.8× 125 0.7× 51 0.3× 58 0.4× 61 0.8× 40 986
Linda Duffy United States 3 547 1.2× 212 1.1× 625 3.3× 40 0.3× 95 1.2× 5 919
Chien-Kuo Tai Taiwan 13 583 1.3× 327 1.7× 165 0.9× 46 0.4× 125 1.6× 23 801
Donna Cook United States 6 1.0k 2.3× 148 0.8× 87 0.5× 218 1.7× 42 0.5× 8 1.1k
Naim Shabani Germany 16 449 1.0× 179 0.9× 201 1.1× 44 0.3× 69 0.9× 34 938
M. Pichon France 16 183 0.4× 180 1.0× 259 1.4× 87 0.7× 113 1.4× 42 690
Rebecca R. Hozak United States 18 441 1.0× 55 0.3× 433 2.3× 296 2.3× 183 2.3× 36 1.0k
Andrea Clocchiatti United States 15 511 1.1× 89 0.5× 233 1.2× 78 0.6× 106 1.4× 17 823

Countries citing papers authored by Haruki Kaku

Since Specialization
Citations

This map shows the geographic impact of Haruki Kaku's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haruki Kaku with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haruki Kaku more than expected).

Fields of papers citing papers by Haruki Kaku

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haruki Kaku. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haruki Kaku. The network helps show where Haruki Kaku may publish in the future.

Co-authorship network of co-authors of Haruki Kaku

This figure shows the co-authorship network connecting the top 25 collaborators of Haruki Kaku. A scholar is included among the top collaborators of Haruki Kaku based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haruki Kaku. Haruki Kaku is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sakaguchi, Masakiyo, Masami Watanabe, Rie Kinoshita, et al.. (2014). Dramatic Increase in Expression of a Transgene by Insertion of Promoters Downstream of the Cargo Gene. Molecular Biotechnology. 56(7). 621–630. 48 indexed citations
3.
Ma, Chao, Chunxiao Liu, Peng Huang, et al.. (2014). Significant association between the Axin2 rs2240308 single nucleotide polymorphism and the incidence of prostate cancer. Oncology Letters. 8(2). 789–794. 25 indexed citations
4.
Watanabe, Masami, Masakiyo Sakaguchi, Rie Kinoshita, et al.. (2013). A novel gene expression system strongly enhances the anticancer effects of a REIC/Dkk-3-encoding adenoviral vector. Oncology Reports. 31(3). 1089–1095. 23 indexed citations
5.
Liu, Chunxiao, Shaobo Zheng, Haiyan Shen, et al.. (2013). Clinical significance of CD24 as a predictor of bladder cancer recurrence. Oncology Letters. 6(1). 96–100. 26 indexed citations
6.
Nakamura, Aya, Masami Watanabe, Sabina Mahmood, et al.. (2012). Dose-response analysis of testosterone replacement therapy in patients with female to male gender identity disorder. Endocrine Journal. 60(3). 275–281. 78 indexed citations
7.
Hirata, Takeshi, Masami Watanabe, Haruki Kaku, et al.. (2012). REIC/Dkk-3-encoding adenoviral vector as a potentially effective therapeutic agent for bladder cancer. International Journal of Oncology. 41(2). 559–564. 17 indexed citations
8.
Huang, Peng, Jie Chen, Lei Wang, et al.. (2011). Implications of transcriptional factor, OCT-4, in human bladder malignancy and tumor recurrence. Medical Oncology. 29(2). 829–834. 44 indexed citations
9.
Ochiai, Kazuhiko, Masami Watanabe, Peng Huang, et al.. (2011). Tumor suppressor REIC/Dkk-3 interacts with the dynein light chain, Tctex-1. Biochemical and Biophysical Research Communications. 412(2). 391–395. 22 indexed citations
10.
Sasaki, Koji, Yasutomo Nasu, Haruki Kaku, et al.. (2011). A phase I/II study of adenovirus-mediated interleukin-12 gene therapy for hormone refractory prostate cancer: An interim report.. Journal of Clinical Oncology. 29(7_suppl). 148–148. 2 indexed citations
11.
Huang, Peng, Haruki Kaku, Yuji Kashiwakura, et al.. (2010). Potent antitumor effects of combined therapy with a telomerase-specific, replication-competent adenovirus (OBP-301) and IL-2 in a mouse model of renal cell carcinoma. Cancer Gene Therapy. 17(7). 484–491. 16 indexed citations
12.
Huang, Peng, Masami Watanabe, Haruki Kaku, et al.. (2008). Direct and distant antitumor effects of a telomerase-selective oncolytic adenoviral agent, OBP-301, in a mouse prostate cancer model. Cancer Gene Therapy. 15(5). 315–322. 31 indexed citations
13.
Murakami, Takanori, Shin Ebara, Takashi Saika, et al.. (2007). Routine transurethral biopsy of the bladder is not necessary to evaluate the response to bacillus calmette-guerin therapy.. PubMed. 61(6). 341–4. 8 indexed citations
14.
Abarzúa, Fernando, Masakiyo Sakaguchi, Ryuta Tanimoto, et al.. (2007). Heat shock proteins play a crucial role in tumor-specific apoptosis by REIC/Dkk-3. International Journal of Molecular Medicine. 20(1). 37–43. 24 indexed citations
15.
Kaku, Haruki, Takashi Saika, Tomoyasu Tsushima, et al.. (2006). Combination chemotherapy with estramustine phosphate, ifosfamide and cisplatin for hormone-refractory prostate cancer.. PubMed. 60(1). 43–9. 10 indexed citations
16.
Kaku, Haruki, Sachio Ito, Shin Ebara, et al.. (2004). Positive correlation between allelic loss at chromosome 14q24-31 and poor prognosis of patients with renal cell carcinoma. Urology. 64(1). 176–181. 13 indexed citations
17.
Saika, Takashi, Tomoyasu Tsushima, Yasutomo Nasu, et al.. (2003). Anterior urethral recurrence of superficial bladder cancer: its clinical significance.. Okayama University Scientific Achievement Repository (Okayama University). 57(6). 293–7. 2 indexed citations
18.
Kaku, Haruki, Tomoyasu Tsushima, Yasutomo Nasu, et al.. (2002). Combination chemotherapy with estramustine phosphate, ifosfamide and cis-platin in hormone-refractory prostate cancer. 64(4). 236–241. 1 indexed citations
19.
Kaku, Haruki, Tomoyasu Tsushima, Yasutomo Nasu, & Hiromi Kumon. (2002). [Time to normalization of testosterone after withdrawal of long time LH-RH agonist therapy in prostate cancer].. PubMed. 60 Suppl 11. 182–7. 2 indexed citations
20.
Shimura, Satoru, Yasutomo Nasu, Haruki Kaku, et al.. (2002). Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters. Prostate Cancer and Prostatic Diseases. 5(4). 316–325. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Waleed Arafat Breakdown of academic impact, for papers by Ida Casciano Breakdown of academic impact, for papers by Nora Krull Breakdown of academic impact, for papers by Linda Duffy Breakdown of academic impact, for papers by Chien-Kuo Tai Breakdown of academic impact, for papers by Donna Cook Breakdown of academic impact, for papers by Naim Shabani Breakdown of academic impact, for papers by M. Pichon Breakdown of academic impact, for papers by Rebecca R. Hozak Breakdown of academic impact, for papers by Andrea Clocchiatti
Rankless by CCL
2026